Table. 3.

Incidence and Severity of CRBD in Patients Undergoing Transurethral Resection of the Bladder Tumor

Catheter related bladder discomfort Group 1 (n = 30) Group 2 (n = 30) P value
Postoperative hr
0 hr
Incidence 27 (90.0) 30 (100)
Severity < 0.001
Mild 12 (40.0) 1 (3.3)
Moderate 15 (50.0) 15 (50.0)
Severe 0 (0) 14 (46.7)
1 hr
Incidence 21 (70.0) 30 (100)
Severity < 0.001
Mild 19 (63.3) 2 (6.7)
Moderate 2 (6.7) 17 (56.7)
Severe 0 (0) 11 (36.7)
6 hr
Incidence 12 (40.0) 30 (100)
Severity < 0.001
Mild 12 (40.0) 9 (30.0)
Moderate 0 (0) 19 (63.3)
Severe 0 (0) 2 (6.7)
12 hr
Incidence 3 (10.0) 29 (96.7)
Severity < 0.001
Mild 3 (10.0) 22 (73.3)
Moderate 0 (0) 7 (23.3)
Severe 0 (0) 0 (0)
24 hr
Incidence 0 (0) 24 (80.0)
Severity < 0.001
Mild 0 (0) 18 (60.0)
Moderate 0 (0) 6 (20.0)
Severe 0 (0) 0 (0)

Values are presented as number (%).

CRBD: catheter-related bladder discomfort, group 1: the atropine group, group 2: sugammadex group.

Korean J Pain 2020;33:176~182 https://doi.org/10.3344/kjp.2020.33.2.176
© Korean J Pain